TALLAHASSEE, Fla., Aug. 18 -- Florida State University issued the following news release:
As GLP-1 drugs become increasingly common for weight loss, researchers are beginning to examine what these medications may reveal about eating behavior beyond the scale, including why some people experience persistent urges to binge.
Florida State University's Pamela Keel, the Robert O. Lawton Distinguished Professor of Psychology, has developed emerging research suggesting GLP-1 drugs may help reduce binge-eating symptoms in some patients by addressing a biological factor rather than simply targeting willpower or behavior.
Keel led the research team whose work last summer established that overlooked biological components in bulimia could be targete...